Patents by Inventor Anthony Robert Milnes Coates

Anthony Robert Milnes Coates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISINFECTANT COMPOSITION
    Publication number: 20230337671
    Abstract: The present invention concerns the use of a low concentration of 4-methyl-8-phenoxy-1-(2- phenylethyl)-2,3-dihydro-1H-pyrrolo[3,2-c]quinoline or a pharmaceutically acceptable salt and/or solvate thereof as an emollient in an aqueous disinfectant composition. Also provided is an aqueous disinfectant composition and the use thereof in one or more consumer products and disinfectant methods.
    Type: Application
    Filed: August 17, 2021
    Publication date: October 26, 2023
    Applicant: Helperby Therapeutics Limited
    Inventors: George Bridge, Professor Anthony Robert Milnes Coates, Paul Pelham
  • Peptides from chaperonin 60.1
    Patent number: 9320791
    Abstract: Peptides from the polypeptide chaperonin 60.1, and their use in medicine for the treatment of inflammatory conditions are described.
    Type: Grant
    Filed: May 14, 2014
    Date of Patent: April 26, 2016
    Assignee: PEPTINNOVATE LIMITED
    Inventors: Anthony Robert Milnes Coates, Peter Tormay, Andrew Lightfoot
  • BIOLOGICAL MATERIALS AND USES THEREOF
    Publication number: 20160017009
    Abstract: The present invention concerns a peptide molecule or a nucleic acid molecule, for use in medicine and, in particular, for use in preventing or treating a non-cancerous condition or relieving pain in a patient. The invention also relates to a pharmaceutical composition comprising the peptide or nucleic acid molecule of the invention and methods of treatment thereof.
    Type: Application
    Filed: July 17, 2015
    Publication date: January 21, 2016
    Inventors: Anthony Robert Milnes Coates, Yanira Riffo-Vasquez, Peter Tormay
  • Biological materials and uses thereof
    Patent number: 9085632
    Abstract: The present invention concerns a peptide molecule or a nucleic acid molecule, for use in medicine and, in particular, for use in preventing or treating a non-cancerous condition or relieving pain in a patient. The invention also relates to a pharmaceutical composition comprising the peptide or nucleic acid molecule of the invention and methods of treatment thereof.
    Type: Grant
    Filed: February 25, 2009
    Date of Patent: July 21, 2015
    Assignee: PEPTINNOVATE LIMITED
    Inventors: Anthony Robert Milnes Coates, Yanira Riffo-Vasquez, Peter Tormay
  • Novel pepetides
    Publication number: 20140341932
    Abstract: The present invention relates to novel peptides derivable from the polypeptide chaperonin 60.1 and to their use in medicine, such as for the prevention and/or treatment of inflammatory conditions.
    Type: Application
    Filed: May 14, 2014
    Publication date: November 20, 2014
    Inventors: Anthony Robert Milnes Coates, Peter Tormay, Andrew Lightfoot
  • Biological materials and uses thereof
    Publication number: 20110052616
    Abstract: The present invention concerns a peptide molecule or a nucleic acid molecule, for use in medicine and, in particular, for use in preventing or treating a non-cancerous condition or relieving pain in a patient. The invention also relates to a pharmaceutical composition comprising the peptide or nucleic acid molecule of the invention and methods of treatment thereof.
    Type: Application
    Filed: February 25, 2009
    Publication date: March 3, 2011
    Applicant: Helperby Therapeutics Limited
    Inventors: Anthony Robert Milnes Coates, Yanira Riffo-Vasquez, Peter Tormay
  • Screening process for antibacterial agents
    Patent number: 7892782
    Abstract: The present invention relates to a method of preparing a phenotypically antibiotic-resistant subpopulation of stationary phase bacteria by treating stationary phase bacteria with high doses of antibacterial agents, the subpopulation thus identified, a process for identifying new antibacterial agents by testing against the antibiotic-resistant subpopulation, the compounds thus identified and their uses, particularly in treating bacterial infections involving dormant bacteria.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: February 22, 2011
    Assignee: Helperby Therapeutics Limited
    Inventors: Anthony Robert Milnes Coates, Yanmin Hu
  • Pain relief agents
    Patent number: 7744906
    Abstract: The present invention concerns the use of a heat shock polypeptide and/or an encoding nucleic acid sequence in the manufacture of a medicament for use in the relief of pain. In particular the invention concerns the use of chaperonin. The invention further provides methods of relieving pain medicaments containing the heat shock polypeptides.
    Type: Grant
    Filed: November 5, 2003
    Date of Patent: June 29, 2010
    Assignee: Helperby Therapeutics Limited
    Inventor: Anthony Robert Milnes Coates
  • SCREENING PROCESS FOR ANTIBACTERIAL AGENTS
    Publication number: 20090104651
    Abstract: The present invention relates to a method of preparing a phenotypically antibiotic-resistant subpopulation of stationary phase bacteria by treating stationary phase bacteria with high doses of antibacterial agents, the subpopulation thus identified, a process for identifying new antibacterial agents by testing against the antibiotic-resistant subpopulation, the compounds thus identified and their uses, particularly in treating bacterial infections involving dormant bacteria.
    Type: Application
    Filed: December 23, 2008
    Publication date: April 23, 2009
    Inventors: Anthony Robert Milnes COATES, Yanmin Hu
  • Biological materials and uses thereof
    Publication number: 20040132163
    Abstract: The invention relates to pharmaceutical compositions of an approx 60kDa polypeptide (or its encoding nucleic acid molecules) or functionally equivalent molecules or fragments thereof from Mycobacterium tuberculosis or related prokaryotes in the treatment of non-cancerous pathological conditions such as autoimmune and allergic disorders.
    Type: Application
    Filed: January 26, 2004
    Publication date: July 8, 2004
    Inventor: Anthony Robert Milnes Coates
  • Biological materials and uses thereof
    Publication number: 20040127438
    Abstract: The invention relates to the use of cpn 10 from Mycobacterium tuberculosis, or functionally equivalent molecules of fragments thereof, in the prevention and/or treatment of allergic conditions such as asthma, rhinitis/hay fever, eczema and anaphylaxis, which conditions are associated with an underlying Th2 cell over-reactivity, or cancerous conditions.
    Type: Application
    Filed: November 26, 2003
    Publication date: July 1, 2004
    Inventor: Anthony Robert Milnes Coates
  • Screening process for antibacterial agents
    Publication number: 20020031819
    Abstract: The present invention relates to a method of preparing a phenotypically antibiotic-resistant subpopulation of stationary phase bacteria by treating stationary phase bacteria with high doses of antibacterial agents, the subpopulation thus identified, a process for identifying new antibacterial agents by testing against the antibiotic-resistant subpopulation, the compounds thus identified and their uses, particularly in treating bacterial infections involving dormant bacteria.
    Type: Application
    Filed: April 27, 2001
    Publication date: March 14, 2002
    Inventors: Anthony Robert Milnes Coates, Yanmin Hu